Cargando…
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness
To determine whether the early serologic response in COVID-19 critical illness is associated with hospital mortality. To evaluate if time-to-seroconversion differs by receipt of dexamethasone therapy. DESIGN: Patients were prospectively enrolled within 24 hours of ICU admission from two University o...
Autores principales: | Mabrey, F. Linzee, Zelnick, Leila R., Morrell, Eric D., O’Connor, Nicholas G., Hart, Andrew, Wurfel, Mark M., Liles, W. Conrad, Bhatraju, Pavan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426803/ https://www.ncbi.nlm.nih.gov/pubmed/36050993 http://dx.doi.org/10.1097/CCE.0000000000000754 |
Ejemplares similares
-
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
por: Mabrey, F. Linzee, et al.
Publicado: (2022) -
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach
por: Sathe, Neha A., et al.
Publicado: (2023) -
Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19
por: Bhatraju, Pavan K, et al.
Publicado: (2023)